Type 1 Diabetes Mellitus Stakeholder Engagement Innovation Center to Advance Health Equity (U2C Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

This U2C funding opportunity announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 1 diabetes research (SEIC-T1D). A primary goal of the SEIC-T1D is to accelerate equitable engagement of diverse stakeholders (specifically people from NIH designated health disparities populations) in T1D research; particularly those from communities that experience diabetes-related health disparities and live within the healthcare and social systems that negatively impact community members’ and patients’ health. The SEIC-T1D will provide highly specialized research resources to support investigators by fully embedding communities, people living with T1D, and other stakeholders into the full spectrum of research activities through expert consultations and education in principles and methods of community-engaged research. The SEIC-T1D will also establish a network consisting of diverse, multidisciplinary research investigators with expertise in T1D and community-engaged methods, community experts with lived experiences, and representatives of various health and other organizations deemed essential for addressing disparities and advancing health equity in T1D early detection and treatment.


  • Letter of Intent Due Date(s): October 17, 2022

  • Application Due Date: Dec. 20, 2022

RFA-DK-22-019 Expiration Date New Date Dec. 21, 2022 (Original Date: November 18, 2022) per issuance of NOT-DK-23-003

Agency Website



Amount Description

Application budgets are limited to $1,500,000 Direct Costs per year but need to reflect the actual needs of the proposed project.

The maximum project period is 5 years. 

Funding Type





Community Outreach and Engagement
Medical - Clinical Science
Medical - Translational

External Deadline

December 20, 2022